Package 43063-994-30

Brand: bupropion hydrochloride

Generic: bupropion hydrochloride
NDC Package

Package Facts

Identity

Package NDC 43063-994-30
Digits Only 4306399430
Product NDC 43063-994
Product ID 43063-994_415f8bc9-acd1-9b7c-e063-6294a90a03f7
Description

30 TABLET in 1 BOTTLE, PLASTIC (43063-994-30)

Marketing

Marketing Status
Marketed Since 2019-06-20
Brand bupropion hydrochloride
Generic bupropion hydrochloride
Sample Package No

Linked Drug Pages (1)

bupropion Hydrochloride ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "415f8bc9-acd1-9b7c-e063-6294a90a03f7", "openfda": {"unii": ["ZG7E5POY8O"], "rxcui": ["993687"], "spl_set_id": ["434aacf8-87f1-44fc-a66b-92ae0022de0e"], "manufacturer_name": ["PD-Rx Pharmaceuticals, Inc."]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET in 1 BOTTLE, PLASTIC (43063-994-30)", "package_ndc": "43063-994-30", "marketing_start_date": "20190620"}], "brand_name": "bupropion Hydrochloride", "product_id": "43063-994_415f8bc9-acd1-9b7c-e063-6294a90a03f7", "dosage_form": "TABLET", "pharm_class": ["Aminoketone [EPC]", "Dopamine Uptake Inhibitors [MoA]", "Increased Dopamine Activity [PE]", "Increased Norepinephrine Activity [PE]", "Norepinephrine Uptake Inhibitors [MoA]"], "product_ndc": "43063-994", "generic_name": "bupropion Hydrochloride", "labeler_name": "PD-Rx Pharmaceuticals, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "bupropion Hydrochloride", "active_ingredients": [{"name": "BUPROPION HYDROCHLORIDE", "strength": "100 mg/1"}], "application_number": "ANDA206975", "marketing_category": "ANDA", "marketing_start_date": "20160819", "listing_expiration_date": "20261231"}